Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Advanced Healthcare Materials|July 7, 2026
Gardiquimod Nanoemulsion Targets Cutaneous Leishmaniasis Lesions Reducing Systemic Toxicity and Parasite BurdenCarmen Palomino-Cano, M Carmen Mera-Delgado, Esther Moreno, et al.Oncoimmunology|September 14, 2016
Interferon alpha bioactivity critically depends on Scavenger receptor class B type I functionMarcos Vasquez, Jessica Fioravanti, Fernando Aranda, et al.Hepatology (Baltimore, Md.)|February 16, 2012
Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis BItziar Otano, Lester Suarez, Javier Dotor, et al.Molecular Therapy. Methods & Clinical Development|June 2, 2015
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infectionAintzane Zabaleta, Delia D'Avola, Itziar Echeverria, et al.Hepatology (Baltimore, Md.)|December 15, 2010
Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10Nancy Díaz-Valdés, Lorea Manterola, Virginia Belsúe, et al.Journal of Virology|January 19, 2007
Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infectionEsther Larrea, José I Riezu-Boj, Lucía Gil-Guerrero, et al.Journal of Hepatology|March 8, 2013
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis CBruno Sangro, Carlos Gomez-Martin, Manuel de la Mata, et al.Proceedings of the National Academy of Sciences of the United States of America|July 21, 2012
N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatBPetra Van Damme, Marta Lasa, Bogdan Polevoda, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 22, 2006
Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replicationEduardo Huarte, Esther Larrea, Rubén Hernández-Alcoceba, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 29, 2012
CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapySandra Hervas-Stubbs, Uxua Mancheño, Jose-Ignacio Riezu-Boj, et al.Pageof 6